AbbVie Inc., North Chicago, IL.
AbbVie Corporation, Saint-Laurent, QC.
J Obstet Gynaecol Can. 2021 Jan;43(1):10-18. doi: 10.1016/j.jogc.2020.06.022. Epub 2020 Jul 18.
To evaluate fatigue burden and productivity impairments in Canadian women with a self-reported diagnosis of endometriosis (DxE).
From December 2018 to January 2019, Canadian women aged 18-49 years completed an online survey assessing fatigue via the Patient-Reported Outcomes Measurement Information System (PROMIS) Fatigue Short Form 6a questionnaire. Fatigue T-scores were compared between women with and without a DxE, by age and endometriosis symptom severity, using t tests. Women with a DxE completed the Work Productivity and Activity Impairment - Specific Health Problem (WPAI-SHP) questionnaire. The effects of age and hallmark endometriosis symptoms on productivity impairments were assessed via analysis of variance.
Survey data included 2004 women with and 26 528 women without a DxE. Mean fatigue T-scores were 58.5 ± 10.1 in women with a DxE and 59.2 ± 10.1 in women with hallmark endometriosis symptoms (i.e., menstrual or non-menstrual pelvic pain/cramping, dyspareunia) versus 55.2 ± 9.4 in women without a DxE (both P < 0.001). Women with moderate or severe endometriosis symptoms had a mean T-score of 61.2 ± 9.4 versus 55.9 ± 10.1 for women with mild symptoms (P < 0.001). Women with moderate or severe hallmark endometriosis symptoms had mean T-scores of 59.6-62.9 versus 57.0-58.2 for women with mild or no symptoms (all comparisons P < 0.01). Women with a DxE reported 17.1% of work time missed, 41.8% impaired work ability, 46.5% overall work impairment, and 41.4% activity impairment per the WPAI-SHP. Women with a DxE aged 30-34 and 35-39 years consistently experienced the greatest effects of fatigue and productivity impairments.
Canadian women with a DxE experience a substantial fatigue burden and significant productivity impairments.
评估加拿大自我报告子宫内膜异位症(DxE)诊断的女性的疲劳负担和生产力障碍。
2018 年 12 月至 2019 年 1 月,年龄在 18-49 岁的加拿大女性完成了一项在线调查,通过患者报告的结局测量信息系统(PROMIS)疲劳短表 6a 问卷评估疲劳。使用 t 检验比较 DxE 女性与无 DxE 女性的疲劳 T 评分,按年龄和子宫内膜异位症症状严重程度进行比较。患有 DxE 的女性完成了工作生产力和活动障碍-特定健康问题(WPAI-SHP)问卷。通过方差分析评估年龄和标志性子宫内膜异位症症状对生产力障碍的影响。
调查数据包括 2004 名患有 DxE 的女性和 26528 名无 DxE 的女性。患有 DxE 的女性疲劳 T 评分的平均值为 58.5 ± 10.1,有标志性子宫内膜异位症症状(即月经或非月经盆腔疼痛/痉挛、性交痛)的女性为 59.2 ± 10.1,而无 DxE 的女性为 55.2 ± 9.4(均 P < 0.001)。中重度子宫内膜异位症症状的女性平均 T 评分 61.2 ± 9.4,而轻度症状的女性平均 T 评分 55.9 ± 10.1(P < 0.001)。中重度标志性子宫内膜异位症症状的女性平均 T 评分 59.6-62.9,而轻度或无症状的女性平均 T 评分 57.0-58.2(所有比较 P < 0.01)。患有 DxE 的女性报告的工作时间缺勤率为 17.1%,工作能力受损率为 41.8%,整体工作障碍率为 46.5%,活动障碍率为 41.4%,根据 WPAI-SHP 得出。年龄在 30-34 岁和 35-39 岁的患有 DxE 的女性始终经历最大的疲劳和生产力障碍影响。
加拿大患有 DxE 的女性经历了相当大的疲劳负担和显著的生产力障碍。